Member Info for flava

Very interesting watch

ImmuPharma having received over £5 million from Lanstead, £600,000 more than was originally subscribed, through the benefit of the Lanstead Sharing Agreement.

Best low risk investment option.

ImmuPharma having received over £5 million from Lanstead, £600,000 more than was originally subscribed, through the benefit of the Lanstead Sharing Agreement.

Best low risk investment option.

You’re wrong mate. SP was around 190p so please go and research.

No, the SP was 190p so don’t go there.

Why are cross promoting EUA? Just move away buddy.

What makes you think 40-50p next couple of months? Next weeks? Please explain your comments!

@edde - Great post, i believe this time is a very different story for IMM. The SP should move up to a 40-50p mark by the end of this year, especially with a American Phamra company on board. Next year SP should be around an all time high or more.

https://www.cnbc.com/2019/11/28/reuters-america-immupharma-licenses-lupus-drug-lupuzor-to-avion-in-the-united-states.html

https://www.nytimes.com/reuters/2019/11/28/business/28reuters-immupharma-avion.html

We should be at least 72p especially 144p placing taken place last year.

Very undervalued after last weeks mega news!

Patience is a virtue.

Shut up mate - Get a grip and stop spamming the board. You’re working with your buddy Nolupus lol

Who you think you’re fooling. Nice drama queens

Nolupus - I don't have any personal issue with you but don't keep posting negative and vague information!

Widespread media coverage and interest. Especially after this morning Bloomberg US top EURO coverage.

My short-term SP prediction is 84p before end of December 2019 and 150p - 190p by April 2020.

Nolupus - Why are you here 24hrs posting? if you really believe the SP will rise in 3-4 years?

BP production still on target - here’s the Tweet:

https://twitter.com/ahall822/status/1200695646883323904?s=21

Fantasy - here is the latest update as promised: https://twitter.com/ahall822/status/1200695646883323904?s=21

I honestly believe that the SP should be around 85p short term target by end of this year and heading back to 190p by March 2020.

BTW I’m not a day trader or pump and dump guy. I always invest in companies that I believe in longevity and healthy ROI.

Outside of the US, Immupharma will still have the right to commercialise the drug directly or with partners.

All the deramping fools, please go and hide Inside caves. Watch this fly next week.